Literature DB >> 2713217

Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.

G Sager1, R Jaeger, C Little.   

Abstract

1. The effect of variable alpha 1-acid glycoprotein (AAG) and albumin (HSA) concentrations on the binding of prazosin and propranolol was assessed in plasma after surgery and in mixtures of AAG/HSA with concentrations mimicking those found in vivo. 2. On the pre-operative day the binding of prazosin and propranolol was 94.8% and 89.0%, respectively and 97.3% and 93.2%, respectively, 5 days after surgery. 3. In solutions containing mixtures of highly purified AAG and HSA representing the pre-operative state, 88.6% and 83.9% binding of prazosin and propranolol was observed, whereas for solutions mimicking post-operative plasma, the equivalent values were 94.6% and 91.4%, respectively. 4. The ratios between bound and unbound concentrations of both drugs were closely correlated to the concentrations of AAG, but not to the concentrations of HSA. 5. The present study demonstrates that AAG is responsible for the binding variability of prazosin and propranolol in plasma from post-operative patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713217      PMCID: PMC1379784          DOI: 10.1111/j.1365-2125.1989.tb05355.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

1.  Plasma binding and the affinity of propranolol for a beta receptor in man.

Authors:  D G McDevitt; M Frisk-Holmberg; J W Hollifield; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1976-08       Impact factor: 6.875

2.  Propranolol binding to human serum proteins studied by high-performance liquid chromatography.

Authors:  F Bree; J P Tillement; B Sebille
Journal:  J Chromatogr       Date:  1986-03-07

3.  The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.

Authors:  G H Evans; A S Nies; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030

4.  Sequential changes of plasma proteins after surgical trauma.

Authors:  K F Aronsen; G Ekelund; C O Kindmark; C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

5.  Modification of propranolol binding to alpha-1-acid glycoprotein by serum albumin.

Authors:  L Chauvelot-Moachon; O Marquis; J P Giroud
Journal:  Biochem Pharmacol       Date:  1985-05-01       Impact factor: 5.858

6.  Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid.

Authors:  F Brunner; W E Müller
Journal:  J Pharm Pharmacol       Date:  1985-05       Impact factor: 3.765

7.  Decreased elimination of unbound prazosin in the presence of alpha 1-acid glycoprotein in the rat in vivo.

Authors:  S Oie; F Fiori; J Chiang
Journal:  J Pharmacol Exp Ther       Date:  1987-06       Impact factor: 4.030

8.  Binding of catecholamines to alpha-1 acid glycoprotein, albumin and lipoproteins in human serum.

Authors:  G Sager; H Bratlid; C Little
Journal:  Biochem Pharmacol       Date:  1987-11-01       Impact factor: 5.858

9.  Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.

Authors:  K M Piafsky; O Borgá; I Odar-Cederlöf; C Johansson; F Sjöqvist
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

10.  Interaction between antidepressants and alpha 1-adrenergic receptor antagonists on the binding to alpha 1-acid glycoprotein.

Authors:  D G Ferry; N B Caplan; L X Cubeddu
Journal:  J Pharm Sci       Date:  1986-02       Impact factor: 3.534

View more
  2 in total

Review 1.  Effects of surgery on the pharmacokinetic parameters of drugs.

Authors:  J M Kennedy; A M Riji
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

2.  High-throughput 1,536-well fluorescence polarization assays for α(1)-acid glycoprotein and human serum albumin binding.

Authors:  Adam Yasgar; Silviya D Furdas; David J Maloney; Ajit Jadhav; Manfred Jung; Anton Simeonov
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.